Medical Inhaled Nitric Oxide Market, Forecast 2023-2029

The global Medical Inhaled Nitric Oxide market was valued at US$ 1077.4 million in 2022 and is projected to reach US$ 1921.1 million by 2029, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

This report aims to provide a comprehensive presentation of the global market for Medical Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Inhaled Nitric Oxide. This report contains market size and forecasts of Medical Inhaled Nitric Oxide in global, including the following market information:

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-medical-inhaled-nitric-oxide-forecast-2023-2029-38

Global Medical Inhaled Nitric Oxide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Inhaled Nitric Oxide Market Sales, 2018-2023, 2024-2029, (M L)
Global top five Medical Inhaled Nitric Oxide companies in 2022 (%)

The main medical inhaled Nitric Oxide players include Mallinckrodt, Linde, Air Liquide, etc. The top three Medical Inhaled Nitric Oxide players account for approximately 95% of the total global market. The global medical inhaled Nitric Oxide are mainly produced in United States and Europe, they occupied for a share about 95%. North America is the largest consumer market, accounting for about 77%, followed by Europe and Asia-Pacific, with around 16% and 6% market share respectively.

We surveyed the Medical Inhaled Nitric Oxide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Medical Inhaled Nitric Oxide Market, by NO Concentration, 2018-2023, 2024-2029 ($ Millions) & (M L)

Global Medical Inhaled Nitric Oxide Market Segment Percentages, by NO Concentration, 2022 (%)

800 ppm
100 ppm
Others

Global Medical Inhaled Nitric Oxide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M L)

Global Medical Inhaled Nitric Oxide Market Segment Percentages, by Application, 2022 (%)

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Other Diseases

Global Medical Inhaled Nitric Oxide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M L)

Global Medical Inhaled Nitric Oxide Market Segment Percentages, By Region and Country, 2022 (%)

North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Medical Inhaled Nitric Oxide revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Medical Inhaled Nitric Oxide revenues share in global market, 2022 (%)

Key companies Medical Inhaled Nitric Oxide sales in global market, 2018-2023 (Estimated), (M L)

Key companies Medical Inhaled Nitric Oxide sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Mallinckrodt
Linde
Air Liquide

Outline of Major Chapters:

Chapter 1: Introduces the definition of Medical Inhaled Nitric Oxide, market overview.
Chapter 2: Global Medical Inhaled Nitric Oxide market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by no concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Inhaled Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Inhaled Nitric Oxide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-medical-inhaled-nitric-oxide-forecast-2023-2029-38

CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 / +91 8087042414